MIRA Pharmaceuticals (MIRA)

• Market cap: $29.6M
• 1 day: 9.15%
• 5 days: -8.28%
• 1 month: 19.23%
• 3 months: -13.89%
• 6 months: 68.3%
• Year to date: 34.78%
• 1 year: 44.86%
• 5 years: -79.11%
• 10 years: -79.11%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Employees: 5